COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 30.8K citations · Full text

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Xiaobo Yang, Yu Yuan, Jiqian Xu et al. · The Lancet Respiratory Medicine · 2020 · 10.6K citations · Full text

Clinical Course, Critical Care Medicine, Acute Care +8

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Keiji Kuba, Yumiko Imai, Shuan Rao et al. · Nature Medicine · 2005 · 3.6K citations · Full text

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Vanessa Monteil, Hyesoo Kwon, Patricia Prado et al. · Cell · 2020 · 2.2K citations · Full text

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Fang Li, Wenhui Li, Michael Farzan et al. · Science · 2005 · 2.2K citations

Virus Structure, Crystal Structure, Spike Protein +10